ATE502928T1 - Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung - Google Patents

Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung

Info

Publication number
ATE502928T1
ATE502928T1 AT01992708T AT01992708T ATE502928T1 AT E502928 T1 ATE502928 T1 AT E502928T1 AT 01992708 T AT01992708 T AT 01992708T AT 01992708 T AT01992708 T AT 01992708T AT E502928 T1 ATE502928 T1 AT E502928T1
Authority
AT
Austria
Prior art keywords
kinases
containing heterocyclic
nitrogen
heterocyclic compounds
production
Prior art date
Application number
AT01992708T
Other languages
English (en)
Inventor
James Kanter
Anjali Pandey
James Robinson
Robert Scarborough
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Application granted granted Critical
Publication of ATE502928T1 publication Critical patent/ATE502928T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01992708T 2000-11-01 2001-11-01 Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung ATE502928T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24465500P 2000-11-01 2000-11-01
US25985901P 2001-01-08 2001-01-08
PCT/US2001/045400 WO2002036587A2 (en) 2000-11-01 2001-11-01 Process for the production of 4-quinazolinylpiperazin-1-carboxylic acid phenylamides

Publications (1)

Publication Number Publication Date
ATE502928T1 true ATE502928T1 (de) 2011-04-15

Family

ID=26936702

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01992708T ATE502928T1 (de) 2000-11-01 2001-11-01 Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung

Country Status (7)

Country Link
US (4) US6951937B2 (de)
EP (1) EP1330444B1 (de)
JP (1) JP4564713B2 (de)
AT (1) ATE502928T1 (de)
AU (1) AU2002217999A1 (de)
DE (1) DE60144284D1 (de)
WO (1) WO2002036587A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144284D1 (de) * 2000-11-01 2011-05-05 Millennium Pharm Inc Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
WO2003051849A1 (en) 2001-12-19 2003-06-26 Ube Industries, Ltd. Process for producing quinazolin-4-one and derivative thereof
DE60328461D1 (de) 2002-01-28 2009-09-03 Ube Industries Verfahren zur herstellung eines chinazolin-4-onderivats
WO2005097137A2 (en) * 2004-03-31 2005-10-20 The Scripps Research Institute Advanced quinazoline based protein kinase inhibitors
WO2006020145A2 (en) * 2004-07-19 2006-02-23 The Johns Hopkins University Flt3 inhibitors for immune suppression
US20100179162A1 (en) * 2005-07-20 2010-07-15 Millennium Pharmaceuticals , Inc. Crystal forms of 4-[6-methoxy-7(3-piperidin-1-yl-propoxy) quinazoline-4yl) piperazine-1-carboxylic acid (4-isopropoxyphenyl)-amide
DK1951254T3 (da) * 2005-11-03 2012-05-07 Portola Pharm Inc (4-(6-halo-7-substitueret-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl)¨-5-chlorthiophen-2-yl-sulfonylureaer og former og fremgangsmåder der er relateret dertil
MX2008010953A (es) * 2006-02-28 2008-09-08 Amgen Inc Derivados de cinolina y quinoxalina como inhibidores de la fosfodiesterasa 10.
AU2008247457A1 (en) * 2007-05-02 2008-11-13 Portola Pharmaceuticals, Inc. [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof
JP2012509321A (ja) * 2008-11-21 2012-04-19 ミレニアム ファーマシューティカルズ， インコーポレイテッド 癌および他の疾患または障害の処置のための、４−［６−メトキシ−７−（３−ピペリジン−１−イル−プロポキシ）キナゾリン−４−イル］ピペラジン−１−カルボン酸（４−イソプロポキシフェニル）−アミドの乳酸塩およびその薬学的組成物
CN103242245B (zh) * 2013-05-22 2015-05-20 苏州明锐医药科技有限公司 坦度替尼的制备方法
WO2015009889A1 (en) 2013-07-18 2015-01-22 Concert Pharmaceuticals, Inc. Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
CN104193688A (zh) * 2014-09-04 2014-12-10 埃斯特维华义制药有限公司 厄洛替尼中间体的合成方法
CN104496915B (zh) * 2014-12-19 2017-05-03 华侨大学 一种喹唑啉酮芳香化合物的合成方法

Family Cites Families (122)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800039A (en) 1970-10-21 1974-03-26 Mead Johnson & Co Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines
US4607034A (en) * 1979-10-29 1986-08-19 Mitsubishi Yuka Pharmaceutical Co., Ltd. Quinazoline derivatives and pharmaceutical composition thereof
JPS5677265A (en) * 1979-11-28 1981-06-25 Mitsubishi Yuka Yakuhin Kk Novel quinazoline derivative
JPS58172379A (ja) * 1982-04-02 1983-10-11 Showa Denko Kk 新規なキナゾリン誘導体
JPS60120872A (ja) * 1983-12-01 1985-06-28 Kyowa Hakko Kogyo Co Ltd 新規なヘテロ環状化合物及び強心剤
US4797419A (en) 1986-11-03 1989-01-10 Warner-Lambert Company Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
US5120843A (en) 1987-04-27 1992-06-09 Upjohn Pharmaceutically active amines
IT1222867B (it) 1987-10-12 1990-09-12 Zambon Spa Ftalazino derivati ad attivita' farmaceutica
JPH02167277A (ja) 1988-09-19 1990-06-27 Kyowa Hakko Kogyo Co Ltd 新規なジアジン化合物
JPH0413669A (ja) 1990-04-27 1992-01-17 Mitsui Toatsu Chem Inc 新規ピリミジンジオン誘導体及び該化合物を含有する抗不整脈剤
DK0584222T3 (da) 1991-05-10 1998-02-23 Rhone Poulenc Rorer Int Bis-mono- og bicycliske aryl- og heteroarylforbindelser, som inhiberer EGF- og/eller PDGF-receptor-tyrosinkinase
NZ243082A (en) 1991-06-28 1995-02-24 Ici Plc 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof
US5308850A (en) 1991-09-30 1994-05-03 Merck Frosst Canada, Inc. (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
US5290798A (en) 1991-09-30 1994-03-01 Merck Frosst Canada, Inc. (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis
AU661533B2 (en) 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
TW225528B (de) 1992-04-03 1994-06-21 Ciba Geigy Ag
US5308852A (en) 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis
GB9321557D0 (en) 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
CA2150550A1 (en) 1992-12-01 1994-06-09 Melissa S. Egbertson Fibrinogen receptor antagonists
JP3229693B2 (ja) * 1993-02-22 2001-11-19 協和醗酵工業株式会社 ピペラジン誘導体
DE69422742T2 (de) 1993-03-19 2000-08-17 Merck & Co., Inc. Phenoxyphenylessigsäurederivate
JPH08508291A (ja) 1993-03-29 1996-09-03 ゼネカ・リミテッド 複素環誘導体
BR9407815A (pt) 1993-10-15 1997-05-06 Merck Patent Gmbh Método de ensaio
US5446062A (en) 1993-11-12 1995-08-29 Abbott Laboratories ((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase
US6403577B1 (en) 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
US5496857A (en) 1994-03-17 1996-03-05 Targosz; Eugene F. Whitefly insecticide
US5538991A (en) 1994-09-14 1996-07-23 Merck & Co., Inc. Endothelin antagonists bearing 5-membered heterocyclic amides
GB9510757D0 (en) 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
WO1996009818A1 (en) 1994-09-27 1996-04-04 Merck & Co., Inc. Endothelin receptor antagonists for the treatment of emesis
CA2133231A1 (en) 1994-09-29 1996-03-30 Kuen-Yuan Hwang Process for preparing carbonate compounds
TW321649B (de) 1994-11-12 1997-12-01 Zeneca Ltd
EP0796252A4 (de) 1994-12-09 1998-02-04 Smithkline Beecham Corp Bicyclische fibrinogen antagonisten
ATE446955T1 (de) 1995-03-30 2009-11-15 Pfizer Prod Inc Chinazolinone derivate
GB9508538D0 (en) 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
US5972955A (en) 1995-06-06 1999-10-26 Dr. Reddy's Research Foundation Water soluble C-ring analogues of 20(S)-camptothecin
US5747498A (en) 1996-05-28 1998-05-05 Pfizer Inc. Alkynyl and azido-substituted 4-anilinoquinazolines
EP0836610A1 (de) 1995-06-29 1998-04-22 Novartis AG Diglycosierlierte 1,2-diole als sialyl-lewis x und sialyl-lewis a mimetika.
GB9514265D0 (en) 1995-07-13 1995-09-13 Wellcome Found Hetrocyclic compounds
GB9516709D0 (en) 1995-08-15 1995-10-18 Zeneca Ltd Medicament
AU6966696A (en) 1995-10-05 1997-04-28 Warner-Lambert Company Method for treating and preventing inflammation and atherosclerosis
HUT76265A (en) 1995-10-19 1997-07-28 Gyogyszerkutato Intezet Pyrimidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
AR005600A1 (es) 1996-02-02 1999-06-23 Syngenta Ltd Composiciones herbicidas quimicamente estables de quelatos metalicos de dionas herbicidas, y proceso para su produccion
FR2744450A1 (fr) 1996-02-02 1997-08-08 Pf Medicament Nouvelles naphtylpiperazines derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
FR2744449B1 (fr) 1996-02-02 1998-04-24 Pf Medicament Nouvelles piperazines aromatiques derivees de cycloazanes substitues, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
DK0880508T3 (da) 1996-02-13 2003-06-30 Astrazeneca Ab Quinazolinderivater som VEGF-inhibitorer
CN1116286C (zh) 1996-03-05 2003-07-30 曾尼卡有限公司 4－苯胺基喹唑啉衍生物
GB9707800D0 (en) 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
KR19980018486A (ko) 1996-08-09 1998-06-05 다께다 구니오 디메틸프로판디올 화합물
US6004967A (en) 1996-09-13 1999-12-21 Sugen, Inc. Psoriasis treatment with quinazoline compounds
CA2265630A1 (en) 1996-09-13 1998-03-19 Gerald Mcmahon Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
JP4073961B2 (ja) 1996-10-01 2008-04-09 協和醗酵工業株式会社 含窒素複素環化合物
KR20000064644A (ko) 1997-01-17 2000-11-06 믹에티취 알.지. 진균 감염 치료제로서의 신규한 트리아졸
US6391880B1 (en) 1997-02-13 2002-05-21 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
ATE368665T1 (de) 1997-08-22 2007-08-15 Astrazeneca Ab Oxindolylchinazolinderivate als angiogenesehemmer
JPH1180131A (ja) * 1997-09-01 1999-03-26 Mitsubishi Chem Corp エチニルピリミジン誘導体
DE19743435A1 (de) 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
JP2001519345A (ja) 1997-10-02 2001-10-23 メルク エンド カムパニー インコーポレーテッド プレニルタンパク質トランスフェラーゼの阻害剤
ATE496035T1 (de) 1998-03-31 2011-02-15 Kyowa Hakko Kirin Co Ltd Stickstoffenthaltende heterocyclische verbindungen
CN1308604A (zh) 1998-05-12 2001-08-15 美国家用产品公司 用于治疗胰岛素抗性和高血糖的2,3,5－取代的联苯化合物
CA2334298C (en) 1998-06-08 2008-01-08 Schering Corporation Neuropeptide y5 receptor antagonists
EP0982300A3 (de) 1998-07-29 2000-03-08 Societe Civile Bioprojet Alkylamine ohne Imidazolring als Histamin-H3-antagonisten und deren therapeutische Anwendung
JP2002526538A (ja) 1998-10-01 2002-08-20 アストラゼネカ アクチボラグ 化学化合物
DK1119567T3 (da) 1998-10-08 2005-07-25 Astrazeneca Ab Quinazolinderivater
DE69919212T2 (de) 1998-12-23 2005-07-28 Eli Lilly And Co., Indianapolis Aromatische amiden
US6146560A (en) 1999-01-22 2000-11-14 Behi; Mohammad Process for forming an article from recycled ceramic molding compound
KR20080015482A (ko) 1999-02-10 2008-02-19 아스트라제네카 아베 혈관형성 억제제로서의 퀴나졸린 유도체
DE19911509A1 (de) 1999-03-15 2000-09-21 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
US6806274B1 (en) 1999-07-07 2004-10-19 Astrazeneca Uk Limited Quinazoline derivatives
JP4870304B2 (ja) 1999-09-21 2012-02-08 アストラゼネカ アクチボラグ キナゾリン誘導体およびそれらの医薬品としての使用
GB9922171D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
GB9922173D0 (en) 1999-09-21 1999-11-17 Zeneca Ltd Chemical compounds
EP1218356A1 (de) 1999-09-21 2002-07-03 AstraZeneca AB Chinazoline verbindungen und diese enthaltende pharmazeutische zusammenstellungen
UA74803C2 (uk) 1999-11-11 2006-02-15 Осі Фармасьютікалз, Інк. Стійкий поліморф гідрохлориду n-(3-етинілфеніл)-6,7-біс(2-метоксіетокси)-4-хіназолінаміну, спосіб його одержання (варіанти) та фармацевтичне застосування
JP2003525897A (ja) 2000-03-06 2003-09-02 アストラゼネカ アクチボラグ 治 療
ES2267748T3 (es) 2000-04-07 2007-03-16 Astrazeneca Ab Compuestos de quinazolina.
UA73993C2 (uk) 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
DE60136459D1 (de) 2000-06-24 2008-12-18 Astrazeneca Ab Guanidin-derivate von chinazoin zur behandlung von autoimmunkrankheiten
WO2002002534A1 (en) 2000-07-03 2002-01-10 Astrazeneca Ab Quinazolines with therapeutic use
EP1309567A2 (de) * 2000-08-18 2003-05-14 Millennium Pharmaceuticals, Inc. Stickstoffhaltige heterozyklische verbindungen
MXPA03001359A (es) 2000-08-18 2004-12-13 Millennium Pharm Inc Derivados de quinazolina como inhibidores de cinasa.
ES2354039T3 (es) * 2000-08-18 2011-03-09 Millennium Pharmaceuticals, Inc. Derivados de n-aril-{4-[7-(alcoxi)quinazolin-4-il]piperazinil}carboxamida como inhibidores de pdgfr.
ATE498614T1 (de) 2000-08-18 2011-03-15 Millennium Pharm Inc (chinazolin-4-yl)piperazin-4-ylüthiocarboxamide als hemmer der phosphorylierung eines pdgf- rezeptors
KR100821446B1 (ko) 2000-08-21 2008-04-10 아스트라제네카 아베 퀴나졸린 유도체
DE10042059A1 (de) 2000-08-26 2002-03-07 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
JP2004511479A (ja) 2000-10-13 2004-04-15 アストラゼネカ　アクチボラグ キナゾリン誘導体
EP1326860A1 (de) 2000-10-13 2003-07-16 AstraZeneca AB Quinazolin derivaten
US20040063733A1 (en) 2000-10-25 2004-04-01 Lambert Christine Marie Paul Quinazoline derivatives
DE60144284D1 (de) 2000-11-01 2011-05-05 Millennium Pharm Inc Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
ATE380172T1 (de) 2001-01-26 2007-12-15 Btg Int Ltd Benzylaminanalogen
TWI245761B (en) 2001-03-01 2005-12-21 Telik Inc Antagonists of MCP-1 function and methods of use thereof
US6960580B2 (en) 2001-03-08 2005-11-01 Millennium Pharmaceuticals, Inc. Nitrogenous heterocyclic substituted quinoline compounds
DE60229046D1 (de) 2001-04-19 2008-11-06 Astrazeneca Ab Chinazolin derivate
GB0110797D0 (en) 2001-05-02 2001-06-27 Celltech R&D Ltd Chemical compounds
WO2002092578A1 (en) 2001-05-14 2002-11-21 Astrazeneca Ab Quinazoline derivatives
WO2002092579A1 (en) 2001-05-14 2002-11-21 Astrazeneca Ab 4-anilinoquinazoline derivatives
WO2002092577A1 (en) 2001-05-14 2002-11-21 Astrazeneca Ab Quinazoline derivatives
US7132427B2 (en) 2001-06-21 2006-11-07 Ariad Pharmaceuticals, Inc. Quinazolines and uses thereof
IL158516A0 (en) 2001-06-28 2004-05-12 Pfizer Prod Inc Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion
GB0128122D0 (en) 2001-11-23 2002-01-16 Astrazeneca Ab Therapeutic use
GB0128109D0 (en) 2001-11-23 2002-01-16 Astrazeneca Ab Therapeutic use
AU2002351573A1 (en) 2001-12-12 2003-07-09 Paradata Systems Inc. Global integrated payment system
WO2003051849A1 (en) 2001-12-19 2003-06-26 Ube Industries, Ltd. Process for producing quinazolin-4-one and derivative thereof
JP4498741B2 (ja) 2001-12-24 2010-07-07 アストラゼネカ アクチボラグ オーロラキナーゼ阻害剤としての置換キナゾリン誘導体
DE60328461D1 (de) 2002-01-28 2009-09-03 Ube Industries Verfahren zur herstellung eines chinazolin-4-onderivats
AU2003207291A1 (en) 2002-02-06 2003-09-02 Ube Industries, Ltd. Process for producing 4-aminoquinazoline compound
US7148249B2 (en) 2002-09-12 2006-12-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
GB0223532D0 (en) 2002-10-09 2002-11-13 British Biotech Pharm Antibacterial agents
TWI347946B (en) 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
SE0203828D0 (sv) 2002-12-20 2002-12-20 Astrazeneca Ab Chemical compounds
US7378525B2 (en) 2002-12-23 2008-05-27 Millennium Pharmaceuticals, Inc. CCR8 inhibitors
TW200510311A (en) 2002-12-23 2005-03-16 Millennium Pharm Inc CCr8 inhibitors
US7138412B2 (en) * 2003-03-11 2006-11-21 Bristol-Myers Squibb Company Tetrahydroquinoline derivatives useful as serine protease inhibitors
JP2006523681A (ja) 2003-03-24 2006-10-19 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド Ｄｎａ−ｐｋ阻害剤としてのキサントン、チオキサントンおよびアクリジノン
BRPI0409136A (pt) 2003-04-09 2006-04-25 Japan Tobacco Inc composto heteroaromático pentacìclico e uso medicinal do mesmo
DE602004015110D1 (de) 2003-05-13 2008-08-28 Schering Corp Verbrückte n-arylsulfonylpiperidine als gamma-sekretaseinhibitoren
CA2533824A1 (en) 2003-07-31 2005-02-10 Irm, Llc Bicyclic compounds and compositions as pdf inhibitors
US7456189B2 (en) 2003-09-30 2008-11-25 Boehringer Ingelheim International Gmbh Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
AU2004285053B2 (en) 2003-10-28 2010-10-21 Vertex Pharmaceuticals, Incorporated Benzimidazoles useful as modulators of ion channels
JP5208911B2 (ja) 2009-12-09 2013-06-12 株式会社東芝 空調制御装置および空調制御方法

Also Published As

Publication number Publication date
WO2002036587A3 (en) 2002-08-22
WO2002036587A2 (en) 2002-05-10
DE60144284D1 (de) 2011-05-05
US8536184B2 (en) 2013-09-17
EP1330444A2 (de) 2003-07-30
USRE43098E1 (en) 2012-01-10
JP2004513126A (ja) 2004-04-30
US7709640B2 (en) 2010-05-04
EP1330444B1 (de) 2011-03-23
US20020091130A1 (en) 2002-07-11
US6951937B2 (en) 2005-10-04
US20060167011A1 (en) 2006-07-27
US20100240893A1 (en) 2010-09-23
AU2002217999A1 (en) 2002-05-15
JP4564713B2 (ja) 2010-10-20

Similar Documents

Publication Publication Date Title
ATE502928T1 (de) Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
BR0211119A (pt) Composto, método de tratar um paciente que tenha, ou de prevenir um paciente de pegar, uma doença ou condição, uso de um composto, e, método para fabricar um composto
TW200615266A (en) Organic compounds
WO2001078711A3 (en) Pde-v inhibitors for treatment of parkinson's disease
WO2005047244A3 (en) Inhibition of fgfr3 and treatment of multiple myeloma
PL374191A1 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
UA83899C2 (uk) Сполуки імідазолу для лікування нейродегенеративних розладів
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
LU92323I2 (fr) La combinaison de (a) dextromethorphan ou un de ses sels pharmaceutiquement acceptables, précursers ou dérivés, par ex. hydrobromure de dextromethorphan et en particulier hydrobromure de dextromethorphan monohydrate;et (b) quinidine ou un de ses selspharmacuetiquement acceptables, précurseurs ou dé rivés, par ex. sulfate de quinidine et en particulier sulfate de quinidine dihydrate
MXPA04003245A (es) Hidroxipropilaminas.
WO2001098277A3 (en) Substituted bicyclic derivatives for the treatment of abnormal cell growth
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
TN2022000255A1 (en) Pyrrolopyrimidine amines as complement inhibitors
TW200728260A (en) Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
TW200736229A (en) Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors
TN2022000092A1 (en) Oral complement factor d inhibitors
JOP20220077A1 (ar) مثبطات عامل d المكمل عن طريق الفم
TW200639159A (en) Treatment of pain
AU2001293209A1 (en) Nitrogenous heterocyclic compounds
AU2001293208A1 (en) Nitrogenous heterocyclic compounds
WO2002094768A3 (en) Aza hydroxylated ethyl amine compounds
NO20032411D0 (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
DE60219680D1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties